Aprea Therapeutics (APRE) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.92
-0.81
-0.69
-0.58

Details

Expected EPS
-0.716433
Actual EPS
-0.64
Surprise EPS
0.08
Surprise Percent
+10.67%

Description

⁨Aprea Therapeutics⁩ (⁦APRE⁩) has reported earnings of ⁦-0.64⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts